Burney Co. Sells 1,877 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Burney Co. decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 33,448 shares of the company's stock after selling 1,877 shares during the quarter. Burney Co.'s holdings in HCA Healthcare were worth $11,558,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. City National Bank of Florida MSD increased its position in shares of HCA Healthcare by 23.8% during the 1st quarter. City National Bank of Florida MSD now owns 943 shares of the company's stock worth $326,000 after purchasing an additional 181 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in shares of HCA Healthcare by 5.5% during the 1st quarter. Venturi Wealth Management LLC now owns 5,533 shares of the company's stock worth $1,912,000 after acquiring an additional 290 shares during the last quarter. Oak Thistle LLC increased its holdings in shares of HCA Healthcare by 36.6% during the 1st quarter. Oak Thistle LLC now owns 9,615 shares of the company's stock worth $3,322,000 after acquiring an additional 2,575 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in HCA Healthcare by 18.9% in the 1st quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 149,440 shares of the company's stock valued at $51,639,000 after purchasing an additional 23,702 shares during the period. Finally, Hartford Funds Management Co LLC boosted its stake in HCA Healthcare by 27.3% in the 1st quarter. Hartford Funds Management Co LLC now owns 3,109 shares of the company's stock valued at $1,074,000 after purchasing an additional 666 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Barclays set a $416.00 target price on HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Royal Bank Of Canada restated an "outperform" rating and set a $404.00 price objective (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Finally, Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Eight analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $399.46.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Stock Down 2.1%

Shares of HCA stock traded down $7.22 during trading hours on Friday, reaching $334.26. The company had a trading volume of 3,175,863 shares, compared to its average volume of 1,334,458. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The business has a fifty day simple moving average of $373.81 and a 200-day simple moving average of $345.68. The company has a market cap of $80.41 billion, a price-to-earnings ratio of 14.86, a price-to-earnings-growth ratio of 1.19 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company posted $5.50 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. HCA Healthcare's payout ratio is 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.